NCT00504907View on ClinicalTrials.gov

Safety Study of Oral BTA9881 to Treat RSV Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG

BTA9881

Single oral escalating doses

DRUG

Placebo

Trial Locations (1)

3004

Nucleus Network, Melbourne

All Listed Sponsors
lead

Biota Scientific Management Pty Ltd

INDUSTRY

NCT00504907 - Safety Study of Oral BTA9881 to Treat RSV Infection | Biotech Hunter | Biotech Hunter